Robust Perfusion Deficits in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis

References

1. 1.↵
   1. Rao SM,
   2. Leo GJ,
   3. Bernardin L,
   4. et al

   . Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685–91

   CrossRef
2. 2.↵
   1. Huijbregts SC,
   2. Kalkers NF,
   3. de Sonneville LM,
   4. et al

   . Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004;63:335–39

   CrossRef
3. 3.↵
   1. Rao SM,
   2. Leo GJ,
   3. Ellington L,
   4. et al

   . Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991;41:692–96

   CrossRef
4. 4.↵
   1. Benedict RH,
   2. Wahlig E,
   3. Bakshi R,
   4. et al

   . Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005;231:29–34

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Hoffmann S,
   2. Tittgemeyer M,
   3. von Cramon DY

   . Cognitive impairment in multiple sclerosis. Curr Opin Neurol 2007;20:275–80

   PubMedWeb of Science
6. 6.↵
   1. Chiaravalloti ND,
   2. DeLuca J

   . Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139–51

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Filippi M,
   2. Rocca MA,
   3. Benedict RH,
   4. et al

   . The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010;75:2121–28

   CrossRef
8. 8.↵
   1. Langdon DW

   . Cognition in multiple sclerosis. Curr Opin Neurol 2011;24:244–49

   CrossRefPubMed
9. 9.↵
   1. Rovaris M,
   2. Comi G,
   3. Filippi M

   . MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. J Neurol Sci 2006;245:111–16

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Benedict RH,
    2. Weinstock-Guttman B,
    3. Fishman I,
    4. et al

    . Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61:226–30

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Houtchens MK,
    2. Benedict RH,
    3. Killiany R,
    4. et al

    . Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69:1213–23

    CrossRef
12. 12.↵
    1. Piras MR,
    2. Magnano I,
    3. Canu ED,
    4. et al

    . Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 2003;74:878–85

    Abstract/FREE Full Text
13. 13.↵
    1. Tekok-Kilic A,
    2. Benedict RH,
    3. Weinstock-Guttman B,
    4. et al

    . Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage 2007;36:1294–300

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Rovaris M,
    2. Filippi M,
    3. Minicucci L,
    4. et al

    . Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000;21:402–08

    Abstract/FREE Full Text
15. 15.↵
    1. Roosendaal SD,
    2. Moraal B,
    3. Pouwels PJ,
    4. et al

    . Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 2009;15:708–14

    Abstract/FREE Full Text
16. 16.↵
    1. Calabrese M,
    2. Agosta F,
    3. Rinaldi F,
    4. et al

    . Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009;66:1144–50

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Shin W,
    2. Horowitz S,
    3. Ragin A,
    4. et al

    . Quantitative cerebral perfusion using dynamic susceptibility contrast MRI: evaluation of reproducibility and age- and gender-dependence with fully automatic image postprocessing algorithm. Magn Reson Med 2007;58:1232–41

    CrossRefPubMed
18. 18.↵
    1. Carroll TJ,
    2. Horowitz S,
    3. Shin W,
    4. et al

    . Quantification of cerebral perfusion using the “bookend technique”: an evaluation in CNS tumors. Magn Reson Imaging 2008;26:1352–59

    CrossRefPubMed
19. 19.↵
    1. Srour JM,
    2. Shin W,
    3. Shah S,
    4. et al

    . Scale-PWI a pulse sequence for absolute quantitative cerebral perfusion imaging. J Cereb Blood Flow Metab 2011;31:1272–82

    CrossRefPubMed
20. 20.↵
    1. Inglese M,
    2. Adhya S,
    3. Johnson G,
    4. et al

    . Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab 2008;28:164–71

    CrossRefPubMed
21. 21.↵
    1. Aviv RI,
    2. Francis PL,
    3. Tenenbein R,
    4. et al

    . Decreased frontal lobe gray matter perfusion in cognitively impaired secondary-progressive multiple sclerosis patients detected by the bookend technique. AJNR Am J Neuroradiol. In press
22. 22.↵
    1. Benedict RH,
    2. Fischer JS,
    3. Archibald CJ,
    4. et al

    . Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002;16:381–97

    PubMedWeb of Science
23. 23.↵
    1. Benedict RH,
    2. Zivadinov R

    . Predicting neuropsychological abnormalities in multiple sclerosis. J Neurol Sci 2006;245:67–72

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Blinkenberg M,
    2. Rune K,
    3. Jensen CV,
    4. et al

    . Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 2000;54:558–64

    CrossRef
25. 25.↵
    1. Rashid W,
    2. Parkes LM,
    3. Ingle GT,
    4. et al

    . Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry 2004;75:1288–93

    Abstract/FREE Full Text
26. 26.↵
    1. Morgen K,
    2. Sammer G,
    3. Courtney SM,
    4. et al

    . Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 2006;30:891–98

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Ashburner J

    . Computational anatomy with the SPM software. Magn Reson Imaging 2009;27:1163–74

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Trapp BD,
    2. Peterson J,
    3. Ransohoff RM,
    4. et al

    . Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–85

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Stuss DT,
    2. Alexander MP

    . Is there a dysexecutive syndrome? Philos Trans R Soc Lond B Biol Sci 2007;362:901–15

    Abstract/FREE Full Text
30. 30.↵
    1. Pantoni L,
    2. Garcia JH

    . Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652–59

    Abstract/FREE Full Text
31. 31.↵
    1. Rao SM

    . A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. Milwaukee: Medical College of Wisconsin; 1990
32. 32.↵
    1. Sperling RA,
    2. Guttmann CR,
    3. Hohol MJ,
    4. et al

    . Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol 2001;58:115–21

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Huijbregts SC,
    2. Kalkers NF,
    3. de Sonneville LM,
    4. et al

    . Cognitive impairment and decline in different MS subtypes. J Neurol Sci 2006;245:187–94

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Benedict RH,
    2. Cookfair D,
    3. Gavett R,
    4. et al

    . Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006;12:549–58

    PubMedWeb of Science
35. 35.↵
    1. Forn C,
    2. Belenguer A,
    3. Parcet-Ibars MA,
    4. et al

    . Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT). J Clin Exp Neuropsychol 2008;30:789–96

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Strober L,
    2. Englert J,
    3. Munschauer F,
    4. et al

    . Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler 2009;15:1077–84

    Abstract/FREE Full Text
37. 37.↵
    1. Drake AS,
    2. Weinstock-Guttman B,
    3. Morrow SA,
    4. et al

    . Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler 2010;16:228–37

    Abstract/FREE Full Text
38. 38.↵
    1. Parmenter BA,
    2. Shucard JL,
    3. Benedict RH,
    4. et al

    . Working memory deficits in multiple sclerosis: comparison between the n-back task and the Paced Auditory Serial Addition Test. J Int Neuropsychol Soc 2006;12:677–87

    PubMedWeb of Science
39. 39.↵
    1. Stuss DT,
    2. Floden D,
    3. Alexander MP,
    4. et al

    . Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location. Neuropsychologia. 2001;39:771–86

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Alexander MP,
    2. Stuss DT,
    3. Picton T,
    4. et al

    . Regional frontal injuries cause distinct impairments in cognitive control. Neurology 2007;68:1515–23

    CrossRef